NCT01579994 2020-12-30Crizotinib and Ganetespib (STA-9090) in ALK Positive Lung CancersMemorial Sloan Kettering Cancer CenterPhase 1 Completed13 enrolled
NCT00687934 2014-09-18Study of STA-9090, Administered Once-Weekly in Patients With Solid TumorsSynta Pharmaceuticals Corp.Phase 1 Completed53 enrolled
NCT00688116 2014-09-18Study of STA-9090, Administered Twice-Weekly in Patients With Solid TumorsSynta Pharmaceuticals Corp.Phase 1 Unknown45 enrolled